Event-free survival rate of NODM and MACE was not significantly different between the atorvastatin and rosuvastatin groups (92.5% vs. 90.8%, respectively; Log-rank P-value = 0.550). The current study demonstrated that rosuvastatin had greater efficacy than atorvastatin in producing favorable changes in the atherogenic lipid profile in high-risk patients with hypercholesterolemia. of patients on rosuvastatin and 80% on atorvastatin attained their LDL-C goal. Current Medical Research and … rosuvastatin versus atorvastatin No language restrictions 25 RCTs (n=19,621) resulting in: 28 comparisons of 1:1 dose ratios 20 comparisons of 1:2 dose ratios 6 comparisons of 1:4 dose ratios of rosuvastatin vs. atorvastatin 10 of 25 trials were double blinded Mean study follow-up: 8.6 weeks Law et al. (2003)10 To determine effects of statin Thus atorvastatin (Atorec) at 10mg dose is much less than rosuvastatin (Rosucor) 10mg. The 5-year incidence of MACE for rosuvastatin versus atorvastatin was 4.1% vs. 4.6% for the overall population, 4.5% vs. 4.8% for those with diabetes, and 12.8% vs. 13.8% for those with CVD; corresponding relative risks of MACE were 0.90 (95% CI: 0.8820.92), Patients age 18 years or older who were newly initiated on rosuvastatin or atorvastatin between August 1, 2003, and June 30, 2004, were included. In exceptional cases, it is allowed to be increased to 20mg (maximum range 5-20mg). The correct clinical course of action would have been to increase the dose of atorvastatin to 20mg if … comparing atorvastatin and rosuvastatin, which concluded that atorvastatin has beneficial renal effects compared with rosuvastatin. The first large trial that studied a renal hard outcome as a secondary objective showed that simvastatin combined with ezetimibe had no significant effect on the composite outcome of doubling of serum creatinine and end-stage renal disease, compared with placebo. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. (2003). Rosuvastatin Atorvastatin Pitavastatin Simvastatin Lovastatin Pravastatin Fluvastatin High-Intensity (lowers LDL-C ≥ 50%) 63 40 mg ($196) 62 61 60 80mg ($9 gen, $ 236. br) 59 58 56 20 mg 54 ($196) 52 10 mg ($196) 50 40mg ($9 gen, $ 236. br) Moderate-Intensity (lowers LDL-C 30% to < 50%) br) 48 46 44
Weber Fish Basket Small, Suzuki Gixxer Abs Price In Bangladesh, What Does Non Gmo Mean, Can Aluminum Foil Go In The Air Fryer, Bodyweight Hypertrophy Program,
